LGVN
Longeveron Inc.$0.88-0.02 (-1.77%)Prev Close$0.90·MCap$21.0M·P/E—·Vol173.3K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
16
$182.7K
◆
Net Activity
Net Seller
$182.7K
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Longeveron Inc. (LGVN) has been exclusively selling, with 0 insider purchases totaling $0.00 and 16 insider sales totaling $182.7K. The most recent insider transaction was by Agafonova Nataliya (Chief Medical Officer), who sold $6.1K worth of shares on Jan 2, 2026. Longeveron Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $21.0M.
LGVN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Agafonova Nataliya | Chief Medical Officer | Sell | 10,250 | $0.59 | $6.1K | 0 |
| Jan 2, 2026 | Blass Devin | CTO & SVP of CMC | Sell | 10,700 | $0.59 | $6.3K | 0 |
| Jan 2, 2026 | Lehr Paul T | General Counsel, Secretary | Sell | 6,952 | $0.59 | $4.1K | 0 |
| Jan 2, 2026 | Powell James Nathaniel | Chief Executive Officer | Sell | 2,464 | $0.59 | $1.5K | 0 |
| Oct 1, 2025 | Agafonova Nataliya | Chief Medical Officer | Sell | 11,883 | $0.74 | $8.8K | 0 |
| Oct 1, 2025 | Blass Devin | CTO & SVP of CMC | Sell | 7,609 | $0.74 | $5.6K | 0 |
| Oct 1, 2025 | Lehr Paul T | General Counsel, Secretary | Sell | 4,944 | $0.74 | $3.7K | 0 |
| Oct 1, 2025 | Powell James Nathaniel | Chief Executive Officer | Sell | 2,389 | $0.74 | $1.8K | 0 |
| Jul 1, 2025 | Blass Devin | CTO & SVP of CMC | Sell | 4,599 | $1.28 | $5.9K | 0 |
| Jul 1, 2025 | Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Sell | 13,146 | $1.28 | $16.8K | 0 |
| Jul 1, 2025 | Lehr Paul T | General Counsel, Secretary | Sell | 1,562 | $1.28 | $2.0K | 0 |
| Jul 1, 2025 | Locklear Lisa | Chief Financial Officer | Sell | 7,431 | $1.28 | $9.5K | 0 |
| Jun 23, 2025 | Lehr Paul T | General Counsel, Secretary | Sell | 64,158 | $1.15 | $73.8K | 0 |
| May 29, 2025 | Soffer Rock | Director | Sell | 21,000 | $1.27 | $26.8K | 0 |
| May 22, 2025 | Soffer Rock | Director | Sell | 2,000 | $1.32 | $2.6K | 0 |
| May 16, 2025 | Hare Joshua | Chief Scientific Officer | Sell | 5,250 | $1.40 | $7.4K | 0 |
| Apr 1, 2025 | Agafonova Nataliya | Chief Medical Officer | Sell | 7,566 | $1.50 | $11.3K | 0 |
| Apr 1, 2025 | Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Sell | 13,384 | $1.50 | $20.1K | 0 |
| Apr 1, 2025 | Lehr Paul T | General Counsel, Secretary | Sell | 1,599 | $1.50 | $2.4K | 0 |
| Dec 4, 2024 | Baluch Khoso | Sell | 1,250 | $2.07 | $2.6K | 23,750 | |
| Apr 12, 2024 | Hare Joshua | Chief Scientific Officer | Buy | 148,936 | $2.35 | $350.0K0.6% OS | 633,280+31% |
| Apr 12, 2024 | Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Buy | 10,638 | $2.35 | $25.0K | 19,616+118% |
| Apr 12, 2024 | Soffer Rock | Buy | 138,298 | $2.35 | $325.0K0.6% OS | 208,534+197% | |
| Jan 11, 2024 | Ross Cathy | Buy | 5,000 | $1.31 | $6.5K | 10,000+100% | |
| Jan 2, 2024 | Baluch Khoso | Buy | 10,000 | $1.43 | $14.3K | 15,000+200% | |
| Dec 29, 2023 | PFEFFER JEFFREY | Buy | 10,000 | $1.35 | $13.5K | 15,000+200% | |
| Jun 29, 2023 | Clavijo James | CFO and Treasurer | Sell | 23,532 | $3.47 | $81.5K | 62,303-27% |
| Jan 30, 2023 | Hare Joshua | Chief Scientific Officer | Sell | 20,000 | $4.28 | $85.6K | 7,793,263 |
| Dec 5, 2022 | Hare Joshua | Chief Scientific Officer | Sell | 20,000 | $3.74 | $74.8K | 7,813,263 |
| Oct 18, 2022 | Hare Joshua | Chief Scientific Officer | Sell | 100,000 | $3.61 | $361.0K | 7,813,263 |
| Jun 7, 2022 | Clavijo James | CFO and Treasurer | Sell | 36,955 | $8.26 | $305.2K | 79,619-32% |
| May 24, 2022 | Soffer Rock | Sell | 19,500 | $7.83 | $152.6K | 684,351 | |
| Apr 20, 2022 | Hare Joshua | Chief Scientific Officer | Sell | 20,000 | $10.00 | $200.1K | 7,913,341 |
| Oct 14, 2021 | Green Geoff | CEO | Buy | 1,000 | $3.81 | $3.8K | 139,723 |
| Oct 14, 2021 | Hare Joshua | Chief Scientific Officer | Buy | 2,500 | $3.69 | $9.2K | 7,933,263 |
| Oct 13, 2021 | Soffer Rock | Buy | 19,900 | $3.66 | $72.9K | 51,757+62% | |
| Oct 12, 2021 | Clavijo James | CFO and Treasurer | Buy | 5,000 | $3.34 | $16.7K | 79,598 |
| Oct 12, 2021 | Hare Joshua | Chief Scientific Officer | Buy | 5,000 | $3.39 | $16.9K | 7,930,763 |
| Oct 12, 2021 | Lehr Paul T | General Counsel, Secretary | Buy | 1,750 | $3.34 | $5.8K | 116,366 |
LGVN Insider Buying Activity
The following table shows recent insider purchases of Longeveron Inc. (LGVN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 12, 2024 | Hare Joshua | Chief Scientific Officer | Buy | 148,936 | $2.35 | $350.0K0.6% OS | 633,280+31% |
| Apr 12, 2024 | Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Buy | 10,638 | $2.35 | $25.0K | 19,616+118% |
| Apr 12, 2024 | Soffer Rock | Buy | 138,298 | $2.35 | $325.0K0.6% OS | 208,534+197% | |
| Jan 11, 2024 | Ross Cathy | Buy | 5,000 | $1.31 | $6.5K | 10,000+100% | |
| Jan 2, 2024 | Baluch Khoso | Buy | 10,000 | $1.43 | $14.3K | 15,000+200% | |
| Dec 29, 2023 | PFEFFER JEFFREY | Buy | 10,000 | $1.35 | $13.5K | 15,000+200% | |
| Oct 14, 2021 | Green Geoff | CEO | Buy | 1,000 | $3.81 | $3.8K | 139,723 |
| Oct 14, 2021 | Hare Joshua | Chief Scientific Officer | Buy | 2,500 | $3.69 | $9.2K | 7,933,263 |
| Oct 13, 2021 | Soffer Rock | Buy | 19,900 | $3.66 | $72.9K | 51,757+62% | |
| Oct 12, 2021 | Clavijo James | CFO and Treasurer | Buy | 5,000 | $3.34 | $16.7K | 79,598 |
| Oct 12, 2021 | Hare Joshua | Chief Scientific Officer | Buy | 5,000 | $3.39 | $16.9K | 7,930,763 |
| Oct 12, 2021 | Lehr Paul T | General Counsel, Secretary | Buy | 1,750 | $3.34 | $5.8K | 116,366 |
LGVN Insider Selling Activity
The following table shows recent insider sales of Longeveron Inc. (LGVN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Agafonova Nataliya | Chief Medical Officer | Sell | 10,250 | $0.59 | $6.1K | 0 |
| Jan 2, 2026 | Blass Devin | CTO & SVP of CMC | Sell | 10,700 | $0.59 | $6.3K | 0 |
| Jan 2, 2026 | Lehr Paul T | General Counsel, Secretary | Sell | 6,952 | $0.59 | $4.1K | 0 |
| Jan 2, 2026 | Powell James Nathaniel | Chief Executive Officer | Sell | 2,464 | $0.59 | $1.5K | 0 |
| Oct 1, 2025 | Agafonova Nataliya | Chief Medical Officer | Sell | 11,883 | $0.74 | $8.8K | 0 |
| Oct 1, 2025 | Blass Devin | CTO & SVP of CMC | Sell | 7,609 | $0.74 | $5.6K | 0 |
| Oct 1, 2025 | Lehr Paul T | General Counsel, Secretary | Sell | 4,944 | $0.74 | $3.7K | 0 |
| Oct 1, 2025 | Powell James Nathaniel | Chief Executive Officer | Sell | 2,389 | $0.74 | $1.8K | 0 |
| Jul 1, 2025 | Blass Devin | CTO & SVP of CMC | Sell | 4,599 | $1.28 | $5.9K | 0 |
| Jul 1, 2025 | Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Sell | 13,146 | $1.28 | $16.8K | 0 |
| Jul 1, 2025 | Lehr Paul T | General Counsel, Secretary | Sell | 1,562 | $1.28 | $2.0K | 0 |
| Jul 1, 2025 | Locklear Lisa | Chief Financial Officer | Sell | 7,431 | $1.28 | $9.5K | 0 |
| Jun 23, 2025 | Lehr Paul T | General Counsel, Secretary | Sell | 64,158 | $1.15 | $73.8K | 0 |
| May 29, 2025 | Soffer Rock | Director | Sell | 21,000 | $1.27 | $26.8K | 0 |
| May 22, 2025 | Soffer Rock | Director | Sell | 2,000 | $1.32 | $2.6K | 0 |
| May 16, 2025 | Hare Joshua | Chief Scientific Officer | Sell | 5,250 | $1.40 | $7.4K | 0 |
| Apr 1, 2025 | Agafonova Nataliya | Chief Medical Officer | Sell | 7,566 | $1.50 | $11.3K | 0 |
| Apr 1, 2025 | Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Sell | 13,384 | $1.50 | $20.1K | 0 |
| Apr 1, 2025 | Lehr Paul T | General Counsel, Secretary | Sell | 1,599 | $1.50 | $2.4K | 0 |
| Dec 4, 2024 | Baluch Khoso | Sell | 1,250 | $2.07 | $2.6K | 23,750 | |
| Jun 29, 2023 | Clavijo James | CFO and Treasurer | Sell | 23,532 | $3.47 | $81.5K | 62,303-27% |
| Jan 30, 2023 | Hare Joshua | Chief Scientific Officer | Sell | 20,000 | $4.28 | $85.6K | 7,793,263 |
| Dec 5, 2022 | Hare Joshua | Chief Scientific Officer | Sell | 20,000 | $3.74 | $74.8K | 7,813,263 |
| Oct 18, 2022 | Hare Joshua | Chief Scientific Officer | Sell | 100,000 | $3.61 | $361.0K | 7,813,263 |
| Jun 7, 2022 | Clavijo James | CFO and Treasurer | Sell | 36,955 | $8.26 | $305.2K | 79,619-32% |
| May 24, 2022 | Soffer Rock | Sell | 19,500 | $7.83 | $152.6K | 684,351 | |
| Apr 20, 2022 | Hare Joshua | Chief Scientific Officer | Sell | 20,000 | $10.00 | $200.1K | 7,913,341 |
LGVN Insiders
Similar Stocks to LGVN
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B